Late-breaking Abstract Submission Offered
Got some great data, but missed the July abstract deadline?
Fear not! iSBTc will be accepting late-breaking abstracts in conjunction with the 24th Annual Meeting being held October 29-31, 2009.
Submission for abstracts will be open from August 17 - September 14, 2009 via the iSBTc website. All are invited to submit their late-breaking data for possible presentation.
For more info on late-breaking abstract submission, watch your email or click here.
New Abstract Record Set!
Thanks for your participation! The largest number of abstract submissions in iSBTc's 24 year history was received for the 2009 Annual Meeting. With 24 countries represented through abstract submission, this promises to be a "can't miss" program.
- Wondering what all the buzz is about? Attend the Annual Meeting to find out! Register here.
- Didn't have a chance to submit? Late-breakers will be accepted until Sept. 14!
"Friend of the President" Ribbons
Bernard A. Fox, PhD
iSBTc President
Support research, education, training and
President Bernie Fox!
Show your commitment to the field of cancer immunotherapy/biological therapy by participating in iSBTc's inaugural offering of the "Friend of the President" ribbons. These ribbons can be worn on your name badge at the 2009 meeting to show your dedication to supporting research, education, training and the iSBTc President, Dr. Bernie Fox.
Ribbons can be acquired for a minimum donation of $50 with all proceeds going toward iSBTc's new education fund. Just complete the "Friend of the President" section when registering for the meeting.
Want to support but not attending the Annual Meeting? Complete the order form here! Link to
HOT Topic Symposium: Positive Immunotherapy Clinical Trial Outcomes
Come hear about recent breakthroughs and the latest positive data from the companies and people themselves. This is your chance to discuss and interact with leaders in the field (and in the news!) in an intimate environment. Registration is free with a paid Annual Meeting registration.
Hotel Rooms Going Fast!
Stay in the center of the action! Rooms at the conference hotel in Washington, D.C. are selling quickly. Be sure to make your reservations soon for the iSBTc 24th Annual Meeting and Biomarkers Workshop (October 28-31, 2009).
Rates are $239/night and include perks like free in-room internet and fitness center access.
Reserve your room now by clicking here.
Upcoming Programs
iSBTc Organized:
- iSBTc-FDA-NCI Workshop on Prognostic and Predictive Immunologic Biomarkers in Cancer
October 28, 2009 - Washington, D.C.This interactive workshop is organized around lively discussion and sharing of data on biomarker development. Ultimately, the workshop will define the "state of the art" in assay and cellular product development and standardization.
- iSBTc 2009 Annual Meeting
October 29-31, 2009 - Washington, D.C.This three-day program focuses on the prevailing issues in immunotherapy/biological therapy of cancer. With an outstanding lineup of participants and speakers, the 2009 Annual Meeting promises to deliver innovative science in a meeting environment geared toward interaction and networking.
- iSBTc 2010 Annual Meeting
October 1-4, 2010 - Washington, D.C.
New days/dates! Friday-Monday - I month earlier!
iSBTc Participating:
- Immunotherapy of Cancer Symposium at the European Congress of Immunology
September 16, 2009 - Berlin, Germany
Other Programs of Interest:
- 1st International Workshop in Clinical Cancer Immunotherapy & Translational Research
November 19-21, 2009 - Havana, Cuba
Member Spotlight
Senthamil R. Selvan, PhD Associate Scientific Director Hoag Cancer Center
Meet Senthamil R. Selvan, PhD, Chair of the Public Relations, Publications, and Communications Committee - an outstanding member who has attended every Annual Meeting since 2001!
What are your research interests?
My primary clinical research includes autologous and allogeneic cancer cell vaccine production and characterization; immune-monitoring assays (cellular and humoral immune responses) as well as expression analysis of tumor-associated antigens and prognostic biomarkers of clinical outcomes in metastatic cancer. Consequently, I am interested in cytokine gene expression, regulation and function, and chemoprevention and chemomodulation of tumor and immune response (immunopharmacology/immunotoxicology). Additionally, I am interested in evidence-based complementary and alternative medicine - botanicals of medicinal value with interrelated approach.
My interests in processes and methodologies include directing and coordinating research and development of clinical science projects such as clinical trials, clinical diagnostics, and quality assurance and quality control development, optimization and validation (under GMP and GLP guidelines).
What is the most challenging/interesting thing you're currently working on?
Albeit autologous tumor cell based personalized DC vaccine approach, we have learned that melanoma patients with measurable disease in general did not benefit from the autologous vaccine treatment. However, there are a number of metastatic patients, who were treated previously by other modalities, with no measurable disease at the time of vaccine treatment showed no progression for 34 to 86 months. Such patients had many frequent recurrences before the vaccine treatment. We are intrigued at the possibility of induction of an immune response against tumor stem cells, the ones responsible for growing new tumors; and the relationship between biology of cancer cells and alteration of immune mechanisms, in these patients. My team's current research interest is to unravel these possibilities to design better immunotherapeutic approaches centered on personalized cancer vaccine.
How do you spend your time outside of your professional life?
Gardening, cooking (two years in a row, I've won awards in a "chili" cook off competition to promote the United Way campaign at Hoag Hospital), and spiritual activities with family. I also serve as mentor scientist to elementary, middle and high school students, bachelor and master science students, and medical fellows; as a board member of Community Advisory Committee of gifted and talented education; as a board member of Irvine Multicultural Association to promote "unity in diversity;" and as a committee member of yearly Irvine Global Village Festival to promote the "commonness" in all religions.
Find out more about Dr. Selvan here.